NEW YORK (GenomeWeb News) – Synthetic Genomics today announced today the launch of its wholly owned subsidiary SGI-DNA, and with Integrated DNA Technologies announced a deal between SGI-DNA and IDT to expand an existing collaboration.

SGI-DNA, based in La Jolla, Calif., will be responsible for all aspects of developing, manufacturing, and commercializing Synthetic Genomics' synthetic DNA technology. Fernanda Gandara is general manager of SGI-DNA and will continue as senior vice president of business development for Synthetic Genomics.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Two new Reproducibility Project: Cancer Biology studies have largely reproduced the original findings, ScienceInsider reports.

DNA fingerprinting could catch some sample mix-ups at pathology labs, the New York Times says.

A Maryland police department has turned to DNA phenotyping to develop a suspect sketch, WJLA reports.

In Cell this week: DNA methylation and T cell exhaustion, longevity in C. elegans, and more.